Standard BioTools Inc (NAS:LAB)
$ 2.4 -0.01 (-0.41%) Market Cap: 909.27 Mil Enterprise Value: 892.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 70/100

Fluidigm Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 16, 2020 / 08:00PM GMT
Release Date Price: $6.92 (+3.28%)
Kyle Mikson
Cantor Healthcare - Analyst

Hi, welcome to the Cantor Virtual Global Healthcare Conference. I'm Kyle Mikson. I cover life science tools and diagnostic stocks at Cantor and we're pleased to have Fluidigm here with us today.

Fluidigm creates, manufactures and markets technologies and tools for life sciences' research including prep and analytical instruments for mass cytometry, PCR, library prep, single-cell genomics and consumables. The company is playing a large role in COVID-19 testing effort which I'm sure we'd like to hear much more about in a few moments.

From Fluidigm, we have Chris Linthwaite, the company's President and CEO. If you have a question for Chris, please e-mail to me at [email protected] and I'll relay it to Chris at the end of this presentation. So, thanks for being here, Chris. I'll hand over the floor to you.

Chris Linthwaite
Fluidigm Corporation - President & CEO

Thank you, Kyle, and I want to thank Cantor for the invitation to present at your Healthcare Conference.

So here we go, so the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot